Table 4

Changes in BMI and HbA1c during the 8 years of study among patients with T2DM

First analysis after 16 weeksP valueSecond analysis 52 weeks laterP valueThird analysis 4 years laterP valueFourth analysis 2 years laterP value
BMI*,
M (SD)
Exp.Before30.48 (3.52)<0.000129.4 (5.7)<0.000128 (5.2)<0.00129.17 (5.1)<0.001
After29.9 (3.55)28.2 (9.2)26.42 (4.36)27.33 (4.4)
Cont.Before30.13 (3.35)=0.74030.14 (3.3)<0.00130.02 (4.79)<0.0129.42 (5.1)<0.056
After30.18 (3.21)31.02 (5.1)31.05 (4.84)31.25 (1)
HbA1c,
M (SD)
Exp.Before8.33 (1.29)<0.0018.48 (1.18)<0.0018.51 (2.1)<0.0018.33 (1.2)<0.001
After7.6 (1.04)7.15 (0.82)7.38 (4.8)6.49 (0.6)
Cont.Before8.16 (1.26)=0.6737.97 (0.58)=0.2607.81 (1.8)<0.017.78 (1.2)=0.894
After8.44 (1.22)8.12 (2.1)7.83 (1.1)8.17 (0.98)
  • *BMI, body mass index; M, mean; Exp., experiment group; Cont., control group.